Manulife (Manufacturers Life Insurance)
AGRX

Manulife (Manufacturers Life Insurance)’s Agile Therapeutics AGRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-784
Closed -$4.5M – 3139
2020
Q4 		$4.5M Buy
784
+349
+80% +$2.05M ﹤0.01% 1258
2020
Q3 		$2.65M Buy
435
+414
+1,971% +$2.37M ﹤0.01% 1346
2020
Q2 		$119K Buy
+21
New +$109K ﹤0.01% 2697
2018
Q3 		– Sell
-1
Closed -$1K – 4010
2018
Q2 		$1K Hold
1
– – ﹤0.01% 4269
2018
Q1 		$4K Hold
1
– – ﹤0.01% 4168
2017
Q4 		$4K Buy
+1
New +$9.31K ﹤0.01% 4166
2017
Q3 		– Hold
0
– -$3K – 4380
2017
Q2 		– Hold
0
– – – 4070
2017
Q1 		– Sell
-2
Closed -$10.1K – 3901
2016
Q4 		$19K Buy
+2
New +$28K ﹤0.01% 3650
2016
Q3 		– Hold
0
– – – 3840
2016
Q2 		– Sell
-1
Closed -$13.7K – 3728
2016
Q1 		$16K Buy
+1
New +$12.9K ﹤0.01% 3546
2015
Q4 		– Hold
0
– – – 3935
2015
Q3 		– Hold
0
– – – 3972
2015
Q2 		– Hold
0
– – – 3947
2014
Q4 		– Hold
0
– -$1 – 4066
2014
Q3 		– Hold
0
– – – 3884

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AGRX Position: Q1 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Agile Therapeutics (AGRX) in Q1 2021, closing a stake of 784 shares — an estimated $4.5M sold.

Manulife (Manufacturers Life Insurance) first reported a position in AGRX in Q1 2016 and held it in 8 quarters. The position peaked at $4.5M in Q4 2020. 73 funds tracked by Wall St. Rank hold AGRX as of Q1 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Agile Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 784 Agile Therapeutics shares in Q1 2021, an estimated $4.5M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Agile Therapeutics in Q1 2016 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Agile Therapeutics position peaked at $4.5M in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Agile Therapeutics as of Q1 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2021, filed 3 May 2021.